posted
interesting how they rate success in that article.
it seems to be measured by attraction of VC.
i guess i measure success differently
We have been able to take our lead product program from the initial clinical testing stage in a Phase 1 trial [investigational new drug] to Phase 2 clinical development in nine months, something that most drug discovery and development startups typically achieve ... in three to four years."
"re-spinning" back out of Amgen makes that unremarkable IMO
-------------------- Don't envy the happiness of those who live in a fool's paradise. Posts: 36378 | From: USA | Registered: Sep 2003
| IP: Logged |